Tomohiro Koiwa
Overview
Explore the profile of Tomohiro Koiwa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Furukawa H, Oka S, Higuchi T, Yamaguchi M, Uchiyama S, Koiwa T, et al.
Clin Med Insights Circ Respir Pulm Med
. 2022 Apr;
16:11795484221075492.
PMID: 35401020
Objectives: Coronavirus Disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Serological testing for anti-SARS-CoV-2 nucleocapsid (N) antibodies (Abs) and anti-SARS-CoV-2 spike (S) Abs is...
2.
Sonoda T, Hiejima Y, Koiwa T, Asano M, Kotake E, Yasui A
J AOAC Int
. 2020 Nov;
103(4):1073-1080.
PMID: 33241338
Background: Lutein is gaining attention as a strong antioxidant contained in foods. It accumulates in the human blood and retina, and is considered to play an important role in the...
3.
Takeda K, Suzuki J, Watanabe A, Arai T, Koiwa T, Shinfuku K, et al.
Med Mycol
. 2020 Jul;
59(4):327-334.
PMID: 32642756
The prevalence of azole-resistant Aspergillus fumigatus (ARAF) among chronic pulmonary aspergillosis (CPA) patients treated with azoles in Japan is unknown. The aim of this study was to determine the detection...
4.
Takahashi H, Koiwa T, Fujita A, Suzuki T, Tagashira A, Iwasaki Y
Respir Med Case Rep
. 2020 Jun;
30:101097.
PMID: 32489850
Treatments using immune checkpoint inhibitors such as pembrolizumab lead to immune mediated adverse effects including hemophagocytic lymphohistiocytosis (HLH). Herein, we present a case where HLH developed after pembrolizumab administration, which...
5.
Hasegawa S, Kato H, Hamasaki Y, Koiwa T, Nangaku M
Kidney Int
. 2017 Feb;
91(3):759.
PMID: 28202176
No abstract available.
6.
Takabatake R, Takashima K, Kurashima T, Mano J, Furui S, Kitta K, et al.
J AOAC Int
. 2013 Jun;
96(2):346-52.
PMID: 23767360
Qualitative PCR methods for the genetically modified (GM) maize events MON810, Bt11, and GA21, and the 35S promoter (P35S) region of the cauliflower mosaic virus (CaMV) were evaluated in an...
7.
Mano J, Masubuchi T, Hatano S, Futo S, Koiwa T, Minegishi Y, et al.
Shokuhin Eiseigaku Zasshi
. 2013 Mar;
54(1):25-30.
PMID: 23470871
In this article, we report a novel real-time PCR-based analytical method for quantitation of the GM maize event LY038. We designed LY038-specific and maize endogenous reference DNA-specific PCR amplifications. After...
8.
Takabatake R, Onishi M, Koiwa T, Futo S, Minegishi Y, Akiyama H, et al.
Biol Pharm Bull
. 2013 Jan;
36(1):131-4.
PMID: 23302646
A novel real-time polymerase chain reaction (PCR)-based quantitative screening method was developed for three genetically modified soybeans: RRS, A2704-12, and MON89788. The 35S promoter (P35S) of cauliflower mosaic virus is...
9.
Mano J, Furui S, Takashima K, Koiwa T, Futo S, Minegishi Y, et al.
Shokuhin Eiseigaku Zasshi
. 2012 Nov;
53(4):166-71.
PMID: 23132355
A GM maize event, MIR604, has been widely distributed and an analytical method to quantify its content is required to monitor the validity of food labeling. Here we report a...
10.
Takabatake R, Koiwa T, Kasahara M, Takashima K, Futo S, Minegishi Y, et al.
Shokuhin Eiseigaku Zasshi
. 2011 Aug;
52(4):265-9.
PMID: 21873818
To reduce the cost and time required to routinely perform the genetically modified organism (GMO) test, we developed a duplex quantitative real-time PCR method for a screening analysis simultaneously targeting...